{"id":220896,"date":"2026-05-26T11:13:00","date_gmt":"2026-05-26T15:13:00","guid":{"rendered":"https:\/\/testing.news-you-need.com\/index.php\/2026\/05\/26\/biomunex-announces-strategic-artificial-intelligence-collaborations-to-further-accelerate-the-discovery-and-development-processes-of-its-innovative-pipeline-of-cancer-immunotherapies\/"},"modified":"2026-05-27T06:30:55","modified_gmt":"2026-05-27T10:30:55","slug":"biomunex-announces-strategic-artificial-intelligence-collaborations-to-further-accelerate-the-discovery-and-development-processes-of-its-innovative-pipeline-of-cancer-immunotherapies","status":"publish","type":"post","link":"https:\/\/testing.news-you-need.com\/index.php\/2026\/05\/26\/biomunex-announces-strategic-artificial-intelligence-collaborations-to-further-accelerate-the-discovery-and-development-processes-of-its-innovative-pipeline-of-cancer-immunotherapies\/","title":{"rendered":"Biomunex Announces Strategic Artificial Intelligence Collaborations to Further Accelerate the Discovery and Development Processes of Its Innovative Pipeline of Cancer Immunotherapies"},"content":{"rendered":"<p><a href=\"https:\/\/www.biospace.com\/press-releases\/biomunex-announces-strategic-artificial-intelligence-collaborations-to-further-accelerate-the-discovery-and-development-processes-of-its-innovative-pipeline-of-cancer-immunotherapies\">Biomunex Announces Strategic Artificial Intelligence Collaborations to Further Accelerate the Discovery and Development Processes of Its Innovative Pipeline of Cancer Immunotherapies<\/a><\/p>\n<p><a href=\"https:\/\/www.biospace.com\/press-releases\/biomunex-announces-strategic-artificial-intelligence-collaborations-to-further-accelerate-the-discovery-and-development-processes-of-its-innovative-pipeline-of-cancer-immunotherapies\">https:\/\/www.biospace.com\/press-releases\/biomunex-announces-strategic-artificial-intelligence-collaborations-to-further-accelerate-the-discovery-and-development-processes-of-its-innovative-pipeline-of-cancer-immunotherapies<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-05-26 11:13:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.biospace.com\">www.biospace.com<\/a><\/p>\n<ul>\n<li>Biomunex Pharmaceuticals has announced two strategic collaborations with AI-driven companies, Gordion Bioscience and Tangramed Biotech, to integrate AI into its R&amp;D and support next generation immunotherapies in oncology.<\/li>\n<li>The collaboration with Gordion Bioscience aims to identify novel bispecific target combinations using patient-derived biological network analysis and computational target discovery.<\/li>\n<li>The partnership with Tangramed Biotech focuses on uncovering and prioritizing actionable therapeutic opportunities using multimodal target-combination discovery and generative AI.<\/li>\n<li>Both collaborations are set to leverage Biomunex\u2019s proprietary BiXAb\u00ae platform to accelerate the discovery and development of novel immunotherapies in oncology.<\/li>\n<li>Biomunex aims to combine its BiXAb\u00ae technology with these AI-driven approaches to optimize target selection, shorten discovery timelines, and increase the probability of translational success.<\/li>\n<\/ul>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biomunex Announces Strategic Artificial Intelligence Collaborations to Further Accelerate the Discovery and Development Processes of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":220897,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/static.biospace.com\/dims4\/default\/d32393a\/2147483647\/strip\/true\/crop\/1120x630+40+0\/resize\/1440x810!\/quality\/90\/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2Fcc%2F88%2Fa9fddaf440db946b77e1d45d2e26%2Fbiospace-5.png","fifu_image_alt":"","footnotes":""},"categories":[14],"tags":[20,19],"class_list":["post-220896","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artificial-intelligence","tag-artificial-intelligence","tag-generative-ai"],"_links":{"self":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/220896"}],"collection":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=220896"}],"version-history":[{"count":1,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/220896\/revisions"}],"predecessor-version":[{"id":220898,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/220896\/revisions\/220898"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/220897"}],"wp:attachment":[{"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=220896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=220896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/testing.news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=220896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}